Sanctuary Advisors »

Gain Therapeutics shares owned by Sanctuary Advisors

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Sanctuary Advisors from 13F filings

Historical chart of Sanctuary Advisors investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Sanctuary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Sanctuary Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $20k 10k 2.03

More positions owned by Sanctuary Advisors

NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Vanguard Index Fds Value Etf (VTV)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for Sanctuary Advisors

Top funds holding Gain Therapeutics

Marshall Wace
Potomac Capital Management
GSA Capital Partners
Jones Financial Companies, L.L
Cambridge Investment Research Advisors
DME Capital Management
Vanguard Capital Management
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
UBS Group
Stratos Wealth Partners
Citadel Advisors
Cresset Asset Management
State Street Corporation

View all funds holding Gain Therapeutics